home / stock / abvc / abvc short
Short Information | ABVC BioPharma Inc. (OTCMKTS:ABVC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 15,629 |
Total Actual Volume | 24,382 |
Short Trends | |
---|---|
Cover Days | 8 |
Short Days | 9 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 781 |
Average Short Percentage | 49.25% |
Is there a ABVC Short Squeeze or Breakout about to happen?
See the ABVC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
08-02-2021 | $4.85 | $4.95 | $4.95 | $4 | 5,101 | 5,000 | 98.02% |
07-30-2021 | $4.85 | $4.94 | $4.99 | $4.85 | 571 | 220 | 38.53% |
07-29-2021 | $4.9 | $4.4 | $5.1 | $4.4 | 1,220 | 520 | 42.62% |
07-28-2021 | $5 | $4.7 | $5.1 | $4.7 | 700 | 100 | 14.29% |
07-26-2021 | $4.95 | $5 | $5 | $4.95 | 700 | 300 | 42.86% |
07-23-2021 | $4.95 | $4.95 | $4.95 | $4.95 | 751 | 50 | 6.66% |
07-22-2021 | $4.95 | $5 | $5 | $4.95 | 606 | 6 | 0.99% |
07-21-2021 | $4.9 | $4.95 | $4.95 | $4.9 | 1,000 | 100 | 10% |
07-19-2021 | $4.95 | $5 | $5 | $4.95 | 1,000 | 100 | 10% |
07-07-2021 | $5 | $5 | $5 | $5 | 600 | 100 | 16.67% |
07-06-2021 | $4.9 | $5 | $5 | $4.8 | 900 | 100 | 11.11% |
06-22-2021 | $4.9 | $5 | $5 | $4.9 | 1,304 | 1,304 | 100% |
06-21-2021 | $5 | $5.1 | $5.1 | $5 | 1,200 | 1,000 | 83.33% |
06-18-2021 | $5.25 | $4.75 | $5.3 | $4.3 | 3,000 | 2,500 | 83.33% |
06-17-2021 | $5.2 | $5.2 | $5.3 | $5.2 | 1,200 | 1,000 | 83.33% |
06-16-2021 | $5.2 | $5.2 | $5.2 | $5.2 | 900 | 300 | 33.33% |
06-15-2021 | $5.2 | $5.2 | $5.2 | $5.2 | 1,300 | 1,300 | 100% |
06-14-2021 | $5.2 | $5.35 | $5.35 | $5.2 | 800 | 400 | 50% |
06-11-2021 | $5.2 | $5.2 | $5.2 | $5.2 | 779 | 779 | 100% |
06-10-2021 | $5.2 | $5.25 | $5.25 | $5.2 | 750 | 450 | 60% |
News, Short Squeeze, Breakout and More Instantly...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...
The Company holds a U.S. patent for the same treatment FREMONT, CA - ( NewMediaWire ) - June 25, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, a...
FREMONT, CA - ( NewMediaWire ) - June 12, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company receive...